$LXRX
Lexicon Pharmaceuticals, Inc.
XNAS•Health Care•Pharmaceutical Preparations
$1.46
▼-2.02%-$0.030
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateLexicon Pharmaceuticals, Inc.
XNAS•Health Care•Pharmaceutical Preparations
Why is LXRX down today? It is at $1.46 (-2.02%), and our scanner flagged it 95 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment LXRX spikes, and full due diligence on LXRX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $LXRX 95 times in the last 30 days. Create a free account to track $LXRX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
LXRX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on LXRX today, peaking at 13.0x its normal volume.
Likely catalystLEXICON PHARMACEUTICALS, INC.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filingEFFECTRegistration declared effectiveAug 17, 2026 · 73 days agoAcross every filing on file, supply equal to at least 156.2% of the tradeable float is in play - 156.2% has already been sold.
Some filings did not state a size, so these are floors.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
Recent share offering + active shelf on file — the company raised capital and can raise more
22,384,615 new shares · About $29.1M in size · Priced at $1.3/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Debbane Raymond Director | Other | 89K 0.02% of company | added 4.7% | 2.00M | n/a | Jun 3, 26 |
Amouyal Philippe Director | Other | 89K 0.02% of company | added 31% | 374K | n/a | Jun 3, 26 |
Barker Sam L Director | Other | 89K 0.02% of company | added 72% | 214K | n/a | Jun 3, 26 |
Cheung Ivan Director | Other | 89K 0.02% of company | n/a | 89K | n/a | Jun 3, 26 |
Sobecki Christopher J Director | Other | 89K 0.02% of company | added 44% | 293K | n/a | Jun 3, 26 |
Sullivan Diane E. Director | Other | 89K 0.02% of company | added 100% | 126K | n/a | Jun 3, 26 |
Swain Judith L Director | Other | 89K 0.02% of company | added 100% | 174K | n/a | Jun 3, 26 |
Artal Participations S.A R.L. Director | Other | 20.42M 4.6% of company | added 13% | 175.16M | n/a | Apr 30, 26 |
Exton Michael Officer | Sold (automatic/other) | -205K 0.05% of company | sold 41% | 298K | $301K at $1.47 | Feb 28, 26 |
Exton Michael Officer | Other | 503K 0.1% of company | n/a | 503K | n/a | Feb 28, 26 |
Coiante Scott M Officer | Sold (automatic/other) | -55K 0.01% of company | sold 34% | 105K | $81K at $1.47 | Feb 28, 26 |
Coiante Scott M Officer | Other | 160K 0.04% of company | n/a | 160K | n/a | Feb 28, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
LXRX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on LXRX today, peaking at 13.0x its normal volume.
LXRX last traded at $1.46, down 2.02% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Lexicon Pharmaceuticals, Inc. (LXRX) is next expected to report earnings on Thursday, November 5, 2026, about 7 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The LXRX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged LXRX 95 times in the last 30 days.
LXRX (Lexicon Pharmaceuticals, Inc.) trades on XNAS, with a market cap of about $661M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge LXRX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$LXRX discussion
Sign in to ask a question or join the discussion.